Home Compare SFZN.SW vs WST
Stock Comparison · Comparison

Siegfried Holding vs West Pharmaceutical Services: Which Stock Looks Stronger in 2026?

West Pharmaceutical Services holds the cleaner structural position, with the lead spread across profitability and growth. Siegfried does not offset that deficit through any equally strong structural edge elsewhere. Both sides have seen trend damage — neither carries a clear market edge right now. With both trends damaged, the structural comparison carries most of the weight here.

The comparison is based on similar long-term financial trajectories, not sector labels.

Updated 2026-04-05

The clearest separation starts in profitability, but growth adds another real layer to the result. The overall score gap is 23 points in favour of West Pharmaceutical Services, Inc..

Trajectory Similarity
0.78
Similar
Peer-set rank: #1
within Siegfried Holding AG's functional peer set

This comparison is anchored in long-term financial trajectory similarity within the selected peer universe.

A solid similarity means the pair shares a clearly comparable long-term financial profile, even if individual dimensions still differ.

The clearest structural overlap shows up in revenue growth trajectory and investment intensity.

Similarity drivers
revenue growth trajectoryinvestment intensity
How to read the score
0.85–1.00 · Very similar0.70–0.84 · Similar0.55–0.69 · Moderately similarbelow 0.55 · Loose match
Peer-Relative Score
SFZN.SW
Siegfried Holding AG
44
Peer-Score
Signal qualityMedium
vs
WST
West Pharmaceutical Services, Inc.
67
Peer-Score
Signal qualityHigh

Scores reflect position relative to comparable companies with similar long-term financial trajectories.

Score differences across key dimensions.

Dimension spread: SFZN.SW vs WST Profitability 34 84 Stability 27 50 Valuation 70 61 Growth 38 66 SFZN.SW WST
Gap Ranking
#1 Profitability +50
#2 Growth +28
#3 Stability +23
#4 Valuation +9
Price Setup

Left means cheaper relative valuation. Higher means stronger structure.

Price setup map for SFZN.SW and WST Stronger + cheaper Stronger + richer Weaker + cheaper Weaker + richer SFZN.SWWST Relative valuation Structural strength

West Pharmaceutical Services, Inc. occupies the cheaper side of the setup map, although Siegfried Holding AG still holds the stronger structural profile.

Valuation position uses peer-relative PE percentile (idx_pct_pe) where available.

Relative Position vs Comparable Companies
Profitability
On profitability, West Pharmaceutical Services, Inc. ranks near the top of the group; Siegfried Holding AG sits in the weaker half.
Growth
On growth, the gap still runs the same way: West Pharmaceutical Services, Inc. sits near the top of the group, while Siegfried Holding AG remains in the weaker half.
Profitability — Dominant Gap
SFZN.SW
34
WST
84
Gap+50in favour of WST

Capital efficiency adds support, with a 6.8-point ROIC advantage.

What keeps the gap from being one-sided

Absolute pricing still looks more supportive for Siegfried, with a forward P/E that is 9.2 turns lower there.

What this means for the comparison

The lead is built on both profitability and growth, making it broader than a single-dimension result.

Explore full peer positioning in AssetNext

Break down the SFZN.SW vs WST comparison across all dimensions with the full interactive tool.

Explore full breakdown →
Similar profitability-and-growth comparisons

Explore how SFZN.SW and WST each compare against other companies in their peer groups.

Rule-based, descriptive analysis only. Derived from peer percentile dimensions. Not investment advice. Peer groups are determined algorithmically based on structural similarity — not by sector classification alone.

How AssetNext Peer Scores Work

AssetNext scores reflect each company's structural position within its functional peer group — not a ranking against all stocks simultaneously. Peers are identified by similarity across eight financial dimensions, including revenue growth trajectory, margin structure, capital intensity, and earnings stability. A score of 75 means the company ranks in the top quartile within its own peer group, not the entire market.

Four dimension scores drive the overall peer score: Growth (revenue trajectory and expansion dynamics), Quality (margin structure and capital efficiency), Valuation (peer-relative pricing on standard multiples), and Stability (earnings consistency and financial predictability). Each dimension is scored 0–100 relative to the peer group, then combined into an overall peer score using equal weighting.

Scores are recalculated periodically as underlying financial data is updated. All analysis is descriptive and rule-based — AssetNext describes structural realities and never issues buy, sell or hold recommendations.